Esanex Inc. Report issue

For profit Phase 1 Phase 2
Founded: Indianapolis IN United States (2011)
Status: Defunct (2013)

Organization Overview

First Clinical Trial
2011
NCT00506805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now